Примери за използване на Corticosteroid treatment на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Long-term corticosteroid treatment.
The evolution was marked by rapid regression of lymphadenopathy under corticosteroid treatment.
Corticosteroid treatment unless otherwise specified.
Most cases resolved following corticosteroid treatment.
Corticosteroid treatment usually results in improvement.
In case of chronic toxicity the corticosteroid treatment must be discontinued gradually.
Corticosteroid treatment usually results in improvement.
It is currently unknown if the corticosteroid treatment reverses the gland dysfunction.
Symptoms of differentiation syndrome may recur with premature discontinuation of corticosteroid treatment.
With long-term corticosteroid treatment, growth is often suppressed;
Glaucoma(3.5%) was the most frequent adverse reaction considered related to the corticosteroid treatment(see sections 4.2 and 4.4).
The benefits of the corticosteroid treatment and the possible risks on the growth suppression must be carefully weighed against one another.
Autoimmune pancreatitis(AIP) is a unique form of chronic pancreatitis, andhas a favourable response to corticosteroid treatment(CST).
Although generally effective in the short term for relieving symptoms, corticosteroid treatments do not appear to have a significant impact on long-term recovery.
Fasenra has been shown to be more effective than placebo at reducing the number of asthma flare-ups and the need for corticosteroid treatment.
While a patient is receiving corticosteroid treatment, sweet, fat or salty food intake should be limited in order to minimise the side effects of corticosteroids.
Administration of corticosteroids may be considered; however,the efficacy of corticosteroid treatment in this setting has not been established.
In addition, a reduction in corticosteroid dose was considered clinically relevant,given the potential complications of long-term corticosteroid treatment.
In patients with severe immunosuppression,as a result of prolonged antibiotic or corticosteroid treatment, congenital or acquired immunodeficiency, AIDS, organ or tissue transplantation, the development of opportunistic mycoses is often observed.
If you have been treated for a long time with high doses of inhaled corticosteroid, you may require an extra corticosteroid treatment in times of stress.
To achieve initial remission, or to counteract inflammatory ocular attacks, systemic corticosteroid treatment with daily doses of 0.2 to 0.6 mg/kg prednisone or an equivalent may be added if Sandimmun Neoral alone does not control the situation sufficiently.
As with all intranasal corticosteroids, the total systemic burden of corticosteroids should be considered whenever other forms of corticosteroid treatment are prescribed concurrently.
Adverse reactions found in connection with systemic corticosteroid treatment, such as adrenocortical suppression or impact on the metaboliccontrol of diabetes mellitus, may occur also during topical corticosteroid treatment due to systemic absorption.
The duration of post-treatment prophylaxis should be based on clinical judgment andmay take into account a patient's risk factors such as concomitant corticosteroid treatment and prolonged neutropenia(see section 4.8).
Exploratory subgroup analyses from the clinical trials in Crohn's disease suggested that vedolizumab administered in patients without concomitant corticosteroid treatment may be less effective for induction of remission in Crohn's disease than in those patients already receiving concomitant corticosteroids(regardless of use of concomitant immunomodulators; see section 5.1).
Overeating should be avoided in patients taking corticosteroids, as these drugs increase appetite andfood with high calories and sodium should be avoided during corticosteroid treatment, even if the child is taking a small dose.
However, the CHMP noted that for most of these patients an improvement orrecovering had been observed after corticosteroid treatment or surgery(valve replacement), and in most cases the improvement is stated based on clinical symptoms(no scan).
Special care must be taken in patients with a tumour in the immediate vicinity of an important neurological function and pre-existing focal deficits(e. g. aphasia, vision disturbances, paresis etc.)that do not improve on corticosteroid treatment.
If you feel feverish,- if you have any illness or infection,- if you are having immunosuppressive therapy,e.g. corticosteroid treatment or chemotherapy for cancer, or if you have any condition which makes you prone to infections(immunodeficiency conditions).
Hulio is indicated for the treatment of non-infectious intermediate, posterior and panuveitis in adult patients who have had an inadequate response to corticosteroids, in patients in need of corticosteroid sparing, or in whom corticosteroid treatment is inappropriate.